Breast Cancer Research and Treatment

, Volume 147, Issue 1, pp 223–224 | Cite as

Haste makes waste, but lack of urgency is opportunity lost

Rebuttal Letter
  • 118 Downloads

References

  1. 1.
    Vaidya JS, Wenz F, Bulsara M et al (2014) Risk-adapted targeted intraoperative radiotherapy versus whole-breast radiotherapy for breast cancer: 5-year results for local control and overall survival from the TARGIT-A randomised trial. Lancet 383:603–613CrossRefPubMedGoogle Scholar
  2. 2.
    Group EBCTC (2005) Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet 365:1687–1717CrossRefGoogle Scholar
  3. 3.
    Group EBCTC (2011) Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10 801 women in 17 randomised trials. Lancet 378:1707–1716CrossRefGoogle Scholar
  4. 4.
    Vaidya JS, Joseph DJ, Tobias JS et al (2010) Targeted intraoperative radiotherapy versus whole breast radiotherapy for breast cancer (TARGIT-A trial): an international, prospective, randomised, non-inferiority phase 3 trial. Lancet 376:91–102CrossRefPubMedGoogle Scholar
  5. 5.
    Wickberg A, Holmberg L, Adami HO et al (2014) Sector resection with or without postoperative radiotherapy for stage I breast cancer: 20-year results of a randomized trial. J Clin Oncol 32:791–797CrossRefPubMedGoogle Scholar
  6. 6.
    Vaidya JS, Wenz F, Bulsara M et al (2014) Radiotherapy for breast cancer, the TARGIT-A trial—Authors’ reply. Lancet 383:1719–1720CrossRefPubMedGoogle Scholar
  7. 7.
    Esserman LJ, Alvarado MD, Howe RJ et al (2014) Application of a decision analytic framework for adoption of clinical trial results: are the data regarding TARGIT-A IORT ready for prime time? Breast Cancer Res Treat 144:371–378CrossRefPubMedCentralPubMedGoogle Scholar
  8. 8.
    Darby SC, Ewertz M, McGale P et al (2013) Risk of ischemic heart disease in women after radiotherapy for breast cancer. N Engl J Med 368:987–998CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2014

Authors and Affiliations

  • Laura Esserman
    • 1
  • Mitchell Hayes
    • 1
  • Michael Alvarado
    • 1
  1. 1.University of CaliforniaSan FranciscoUSA

Personalised recommendations